GPT-Rosalind: free biodefense AI for vetted partners
Launched the "Rosalind Biodefense" program, giving vetted developers, U.S. government agencies, and allied partners free API access to a new life-sciences reasoning model, "GPT-Rosalind." Scope is restricted to defensive uses such as epidemiological modeling and biological-threat early detection; initial partners include Lawrence Livermore National Laboratory, Johns Hopkins, and vaccine alliance CEPI
Until now, OpenAI's models were only accessible via the paid public API or ChatGPT's chat interface — and there was no category of life-sciences-specific models. Researchers working on epidemiology or biosecurity had to patch things together with general-purpose GPT-5.5. Over the past few months, biotech startups and public health teams have been pushing for specialized AI support, but model-side readiness wasn't there. Today, OpenAI formally unveiled the Rosalind Biodefense program: free API access to a purpose-built model for epidemiological modeling and biological-threat detection, limited to vetted developers and government partners.
With Lawrence Livermore, Johns Hopkins, and CEPI as launch partners, real-world deployment in defense and public health settings could start quickly. For engineers at research institutes or government agencies, free access without a procurement process is a real advantage. General businesses and individual developers won't get access unless they apply and qualify — so for most people, this is a "watch this space" story rather than an action item. If you're building in biotech-AI, the Rosalind Biodefense application is worth checking.